IRIS
BRUNETTI, JLENIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.799
EU - Europa 6.591
AS - Asia 3.056
SA - Sud America 469
AF - Africa 144
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 17.077
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.695
IT - Italia 1.440
GB - Regno Unito 1.376
RU - Federazione Russa 1.276
CN - Cina 1.005
SG - Singapore 905
IE - Irlanda 722
SE - Svezia 375
BR - Brasile 371
VN - Vietnam 341
DE - Germania 331
UA - Ucraina 280
FR - Francia 278
HK - Hong Kong 230
KR - Corea 167
FI - Finlandia 154
IN - India 116
ZA - Sudafrica 78
ES - Italia 76
CA - Canada 54
BE - Belgio 52
PL - Polonia 50
BD - Bangladesh 48
NL - Olanda 42
AR - Argentina 37
JP - Giappone 33
MX - Messico 32
PK - Pakistan 30
TR - Turchia 29
AT - Austria 27
CH - Svizzera 25
CZ - Repubblica Ceca 24
IR - Iran 22
IQ - Iraq 21
EC - Ecuador 13
NG - Nigeria 13
AU - Australia 12
IL - Israele 12
KE - Kenya 12
PH - Filippine 12
CL - Cile 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
RO - Romania 9
AZ - Azerbaigian 8
CO - Colombia 8
DZ - Algeria 8
PE - Perù 8
TN - Tunisia 8
BG - Bulgaria 7
ID - Indonesia 7
KZ - Kazakistan 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
EE - Estonia 6
EG - Egitto 6
DK - Danimarca 5
JO - Giordania 5
SA - Arabia Saudita 5
AL - Albania 4
ET - Etiopia 4
MA - Marocco 4
NP - Nepal 4
PY - Paraguay 4
RS - Serbia 4
AM - Armenia 3
CR - Costa Rica 3
EU - Europa 3
JM - Giamaica 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
TH - Thailandia 3
TW - Taiwan 3
UY - Uruguay 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GY - Guiana 2
HU - Ungheria 2
LV - Lettonia 2
MM - Myanmar 2
MY - Malesia 2
OM - Oman 2
QA - Qatar 2
SI - Slovenia 2
TJ - Tagikistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
GD - Grenada 1
GE - Georgia 1
Totale 17.064
Salva come PNG Salva come JPEG
Città #
Southend 1.208
Dallas 819
Dublin 712
Fairfield 567
Ashburn 533
Singapore 526
Chandler 402
Siena 398
Moscow 367
San Jose 303
Santa Clara 288
Woodbridge 277
Ann Arbor 272
Beijing 266
Houston 231
Seattle 226
Jacksonville 224
Hong Kong 214
Wilmington 202
Hefei 200
Menlo Park 171
Seoul 163
Cambridge 159
Milan 138
New York 138
Council Bluffs 129
Los Angeles 120
Princeton 104
Florence 99
The Dalles 93
Ho Chi Minh City 90
Munich 81
Johannesburg 74
Helsinki 72
Rome 72
Dong Ket 70
Nanjing 69
Boardman 64
Lauterbourg 63
Hanoi 60
Málaga 48
Shanghai 43
San Diego 41
Fremont 37
Brussels 36
Buffalo 36
London 36
Orem 36
Bengaluru 35
Dearborn 32
Nanchang 31
San Mateo 30
São Paulo 30
Warsaw 27
Hebei 26
Columbus 25
Tokyo 25
Frankfurt am Main 23
Turku 23
Lappeenranta 22
Shenyang 22
Washington 22
Bagno a Ripoli 21
Chicago 21
Atlanta 20
Brooklyn 20
Chennai 20
Naples 19
Tianjin 19
Brno 18
Redondo Beach 18
Vienna 18
Phoenix 17
Porto Alegre 17
Stockholm 17
Düsseldorf 16
Montreal 15
Paris 15
Redwood City 15
Toronto 15
Gdansk 14
Abuja 13
Da Nang 13
Dhaka 13
Kunming 13
Manchester 13
Nuremberg 13
Rio de Janeiro 13
Mexico City 12
Poplar 12
San Francisco 12
Brasília 11
Denver 11
Izmir 11
Amsterdam 10
Guangzhou 10
Mumbai 10
Piscataway 10
Prato 10
Turin 10
Totale 11.505
Salva come PNG Salva come JPEG
Nome #
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 374
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 367
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 365
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 360
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 358
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 355
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 336
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 323
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 321
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 309
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 308
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 303
A new NT4 peptide-based drug delivery system for cancer treatment 303
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 301
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions 300
A CVID-associated variant in the ciliogenesis protein CCDC28B disrupts immune synapse assembly 300
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 299
The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease 296
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 293
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 286
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 284
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 278
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 276
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 275
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 273
Antibacterial and Anti-Inflammatory Activity of Branched Peptides Derived from Natural Host Defense Sequences 263
Branched peptides as bioactive molecules for drug design 260
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 258
Antimicrobial peptides active in in vitro models of endodontic bacterial infections modulate inflammation in human cardiac fibroblasts 254
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 242
Branched peptides as targeting agents for tumor imaging and therapy 239
Nanoparticles exposing neurotensin tumor-specific drivers 237
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 232
Dendrimeric peptide inhibitors of anthrax lethal and edema factors 230
Branched Neurotensin peptides for tumor personalized therapy 225
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 223
Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene 222
Endocytosis and trafficking of heparan sulfate proteoglycans in triple-negative breast cancer cells unraveled with a polycationic peptide 222
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate 219
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 217
A selective Nile Red based solvatochromic probe: A study of fluorescence in LUVs and GUVs model membranes 214
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 213
Turning nonspecific cytotoxic drugs into tumor-selective agents via conjugation to branched peptides. 209
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 208
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents 207
The antimicrobial peptide M33. An example of drug development 207
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 207
Light-Switchable Membrane Permeability in Giant Unilamellar Vesicles 206
Branched oncolytic peptides target HSPGs, inhibit metastasis, and trigger the release of molecular determinants of immunogenic cell death in pancreatic cancer 203
Tumor selective targeting by branched peptides 200
Biochemical characterization and strong in vivo activity of a novel antimicrobial peptide specific for gram-negative bacteria 197
The Bardet-Biedl syndrome complex component BBS1 controls T cell polarity during immune synapse assembly 196
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 193
Increasing LFA-1 Expression Enhances Immune Synapse Architecture and T Cell Receptor Signaling in Jurkat E6.1 Cells 190
In Vivo Efficacy and Toxicity of an Antimicrobial Peptide in a Model of Endotoxin-Induced Pulmonary Inflammation 187
NMR study of the secondary structure and biopharmaceutical formulation of an active branched antimicrobial peptide 187
The Intraflagellar Transport Protein IFT20 Recruits ATG16L1 to Early Endosomes to Promote Autophagosome Formation in T Cells 186
Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases 185
Dendrimeric peptide inhibitors of anthrax lethal and edema factor 182
Target Selective Drug Delivery through Liposome Labeled with Oligobranched Neurotensin Peptides 173
The tardigrade damage suppressor protein modulates transcription factor and DNA repair genes in human cells treated with hydroxyl radicals and UV-C 171
The antimicrobial peptide M33. An example of drug development 168
Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin 166
null 165
Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo 161
Modelling PCDH19 clustering epilepsy by Neurogenin 2 induction of patient-derived induced pluripotent stem cells 160
Solubility improvement of an anthrax toxin peptide inhibitor by rational aminoacid randomization 157
Safety evaluations of a synthetic antimicrobial peptide administered intravenously in rats and dogs 156
Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: antibacterial activity and toxicity in vitro and in vivo 144
Turning Traditional Cytotoxic Drugs Into Tumour-selective Agents 135
null 105
Models of in-vivo Bacterial Infections for the Development of Antimicrobial Peptide-Based Drugs 86
null 78
A peptide-based medical device for the selective removal of inflammatory factors from the blood of people with sepsis 70
Editorial: Proteoglycans in the Tumor Microenvironment 64
Novel role of Hippo effector YAP1 as a rheostat controlling inflammation in dendritic cells 16
Investigating the Cytoprotective Mechanisms of the Tardigrade Damage Suppressor (Dsup) Protein in Human Cells Under Hypoxic Stress 8
Photomodulation of vesicle dynamics using fluorescent photoswitchable amphiphiles 7
Immunomodulatory and Anti-inflammatory Activity in Vitro and in Vivo of a Novel Antimicrobial Candidate 4
Totale 17.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021262 0 0 0 0 0 0 0 0 0 0 106 156
2021/20221.157 71 98 65 100 99 61 57 66 57 145 129 209
2022/20231.493 76 155 180 194 170 248 45 133 111 66 68 47
2023/20241.317 39 33 108 84 75 366 414 35 10 33 30 90
2024/20252.511 77 100 309 125 305 145 116 183 195 92 268 596
2025/20265.748 436 745 718 767 1.201 211 671 181 276 396 146 0
Totale 17.357